INFLUENZA VIRUS STRAIN A/47/SYDNEY/97/14 (H3N2) FOR PRODUCTION OF LIVE INFLUENZAL INTRANASAL VACCINE FOR BABIES

INFLUENZA VIRUS STRAIN A/47/SYDNEY/97/14 (H3N2) FOR PRODUCTION OF LIVE INFLUENZAL INTRANASAL VACCINE FOR BABIES

applied microbiology. SUBSTANCE: vaccinal strain A/47/Sydney/97/14 (H3N2), which is reassortant, is obtained by cross-breeding of epidemic virus A/Sydney/5/97/ (H3N2) with cold-adapted temperature-sensitive virus A/Leningrad/134/47/57 (H2N2), which is attenuation donor. Strain A/47/Sydney/97/14 (H3N...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NAUMENKO Z.S, RUDENKO L.G, ALEKSANDROVA G.I, KLIMOV A.I, KISELEVA I.V
Format: Patent
Sprache:eng ; rus
Schlagworte:
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:applied microbiology. SUBSTANCE: vaccinal strain A/47/Sydney/97/14 (H3N2), which is reassortant, is obtained by cross-breeding of epidemic virus A/Sydney/5/97/ (H3N2) with cold-adapted temperature-sensitive virus A/Leningrad/134/47/57 (H2N2), which is attenuation donor. Strain A/47/Sydney/97/14 (H3N2) actively multiplies in developing chicken embryos at optimal temperature 34 C. Strain is characterized by temperature sensitivity and cold adaptability. Reassortant inherits two genes from epidemic virus, which encode surface proteins (gemmagglutinin and neuraminidase). It also receives six genes encoding non-glycosylated proteins from attenuation donor. In addition, the strain does non induce immune response in babies during intranasal injection. Biological properties and low degree of immunoreactivity meet requirements for vaccine strains. EFFECT: enabled prophylactics of epidemic influenza provoked by specific antigenic virus species. 1 tbl